Xtide 50mg Injection
Prescription Required
Product introduction
Xtide 50mg Injection is used in the treatment of cancer of colon and rectum. It shows its working by stopping or slowing down the growth of cancer cells.
Xtide 50mg Injection is given as an injection into vein by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Nausea, fatigue, vomiting, and diarrhea are some common side effects of this medicine. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. It may cause some serious allergic reaction, inform your doctor if you notice sore lips or mouth ulcers, rash, itching and difficulty breathing. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. It makes men infertile, hence men should take doctor advice about the freezing of sperm before the treatment. You must avoid driving after taking this medicine as it may cause dizziness.
Uses of Xtide Injection
Side effects of Xtide Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Xtide
- Abdominal pain
- Injection site reaction
- Weight gain
- Conjunctivitis
- Fever
- Nosebleeds
- Hair loss
- Constipation
- Skin disorder
- Decreased appetite
- Infection
- Peripheral sensory neuropathy
- Inflammation of the nose
- Pain
- Increased transaminase level in blood
- Increased alkaline phosphatase level in blood
- Taste change
- Edema (swelling)
- Lacrimation disorder
- Allergic reaction
- Fatigue
- Nausea
- Vomiting
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Headache
- Breathlessness
How to use Xtide Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Xtide Injection works
Xtide 50mg Injection is an anti-cancer medication. It works by damaging the genetic material (DNA and RNA) of the cancer cells which stops their growth and multiplication.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Xtide 50mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Xtide 50mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Xtide 50mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Xtide 50mg Injection may cause side effects which could affect your ability to drive.
Xtide 50mg Injection treatment may result in an increased risk of dizziness, nausea, and vomiting, and other neurological symptoms that affect walking and this may affect your ability to drive.
Xtide 50mg Injection treatment may result in an increased risk of dizziness, nausea, and vomiting, and other neurological symptoms that affect walking and this may affect your ability to drive.
Kidney
CAUTION
Xtide 50mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Xtide 50mg Injection may be needed. Please consult your doctor.
Limited information is available on the use of Xtide 50mg Injection in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Limited information is available on the use of Xtide 50mg Injection in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Liver
CAUTION
Xtide 50mg Injection should be used with caution in patients with liver disease. Dose adjustment of Xtide 50mg Injection may be needed. Please consult your doctor.
What if you forget to take Xtide Injection?
If you miss a dose of Xtide 50mg Injection, please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Xtide 50mg Injection
₹1935/Injection
Dacotin 50 Injection
Dr Reddy's Laboratories Ltd
₹2091.9/injection
5% costlier
Oxaltor 50mg Injection
Torrent Pharmaceuticals Ltd
₹1369.04/injection
31% cheaper
Oxoplan 50mg Injection
Samarth Life Sciences Pvt Ltd
₹1322.1/injection
34% cheaper
Celdach 50mg Injection
Celon Laboratories Ltd
₹1740/injection
13% cheaper
Oxichemo 50mg Injection
Lupin Ltd
₹1000/injection
50% cheaper
Quick tips
- Xtide 50mg Injection is given as an injection into veins under the supervision of a doctor.
- Xtide 50mg Injection is given as an injection into veins under the supervision of a doctor.
Fact Box
Chemical Class
Platinum Analogs
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Platinum compounds-Anticancer
Interaction with drugs
Taking Xtide with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Concurrent use may cause a decrease in the ability of the bone marrow to produce blood cells.
Do not consume Oxaliplatin from 1 day before until 1 day after taking Sargramostim. P
Concurrent use may cause a decrease in the ability of the bone marrow to produce blood cells.
Do not consume Lenograstim from 24 hours before until 24 hours after undergoing cytot
Concomitant use may affect heart rhythm.
Do not consume Oxaliplatin with Domperidone.
Concurrent use may cause a decrease in the ability of the bone marrow to produce blood cells.
Do not consume Oxaliplatin from 14 days before until 24 days after taking Pegfilgrast
Concurrent use may cause a decrease in the ability of the bone marrow to produce blood cells.
Do not consume Oxaliplatin from 1 day before until 1 day after taking Molgramostim. P
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1689-90.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 944.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1034-35.
- Oxaliplatin. Hayes, UK: Ranbaxy (UK) Limited a Sun Pharmaceutical Company; 2011 [19 Apr. 2018]. [Accessed 22 Jan. 2019] (online) Available from:
- Oxaliplatin. Bridgewater, New Jersey: sanofi-aventis U.S; 2002 [revised Oct. 2015]. [Accessed 26 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: Biocon
Address: 20th KM, Hosur Road, Electronic City, Bangalore, India - 560 100
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present
